Evaluation of a rapid automated assay for analysis of von Willebrand ristocetin cofactor activity.
about
Hemostatic efficacy, safety, and pharmacokinetics of a recombinant von Willebrand factor in severe von Willebrand diseasePatients Referred for Bleeding Symptoms of Unknown Cause: Does Evaluation of Thrombin Generation Contribute to Diagnosis?Recombinant ADAMTS-13: first-in-human pharmacokinetics and safety in congenital thrombotic thrombocytopenic purpura.Comparison of several von Willebrand factor (VWF) activity assays for monitoring patients undergoing treatment with VWF/FVIII concentrates: improved performance with a new modified automated method.
P2860
Evaluation of a rapid automated assay for analysis of von Willebrand ristocetin cofactor activity.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Evaluation of a rapid automate ...... ristocetin cofactor activity.
@en
Evaluation of a rapid automate ...... ristocetin cofactor activity.
@nl
type
label
Evaluation of a rapid automate ...... ristocetin cofactor activity.
@en
Evaluation of a rapid automate ...... ristocetin cofactor activity.
@nl
prefLabel
Evaluation of a rapid automate ...... ristocetin cofactor activity.
@en
Evaluation of a rapid automate ...... ristocetin cofactor activity.
@nl
P2093
P2860
P1476
Evaluation of a rapid automate ...... ristocetin cofactor activity.
@en
P2093
Andreas Hillarp
Karin Strandberg
Kerstin Andersson
Margareta Carlson
Stefan Lethagen
P2860
P356
10.1177/107602960601200110
P577
2006-01-01T00:00:00Z